J1598
HCPCSInj glycopyrrolate fres kabi
Official HCPCS Level II long descriptor
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
HCPCS Level II code J1598 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj glycopyrrolate fres kabi
Added to HCPCS: 2024-07-01
Nearby codes in J1
- J1574Inj, ganciclovir (exela)
- J1575Hyqvia 100mg immuneglobulin
- J1576Inj, panzyga, 500 mg
- J1577Inj, qivigy, 100mg
- J1580Garamycin gentamicin inj
- J1595Injection glatiramer acetate
- J1596Inj, glycopyrrolate, 0.1 mg
- J1597Inj glycopyrrolate, glyrx-pf
- J1599Ivig non-lyophilized, nos
- J1600Gold sodium thiomaleate inj
- J1602Golimumab for iv use 1mg
- J1610Glucagon hydrochloride/1 mg
- J1611Inj glucagon hcl, fresenius
- J1612Inj glucagon (gvoke) 0.01 mg
- J1626Granisetron hcl injection
- J1627Inj, granisetron, xr, 0.1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.